John A. Bender

Person

Middletown, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immun...
- Patent number 11,505,543
- Issue date Nov 22, 2022
- ViiV HEALTHCARE UK (NO.5) LIMITED
- Makonen Belema
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,954,252
- Issue date Mar 23, 2021
- ViiV HEALTHCARE UK (NO.5) LIMITED
- Suresh Babu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,221,129
- Issue date Mar 5, 2019
- ViiV Healthcare UK (No. 5) Limited
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,035,760
- Issue date Jul 31, 2018
- ViiV Healthcare UK (No. 5) Limited
- Annapurna Pendri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 9,855,230
- Issue date Jan 2, 2018
- ViiV Healthcare UK (No. 5) Limited
- Makonen Belema
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,776,981
- Issue date Oct 3, 2017
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-keto amide derivatives as HIV attachment inhibitors
- Patent number 9,586,957
- Issue date Mar 7, 2017
- ViiV Healthcare UK (No. 5) Limited
- Tao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,561,212
- Issue date Feb 7, 2017
- Bristol-Myers Squibb Company
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,546,160
- Issue date Jan 17, 2017
- Bristol-Myers Squibb Company
- Qi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,340,520
- Issue date May 17, 2016
- Bristol-Myers Squibb Company
- Omar D. Lopez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,809,548
- Issue date Aug 19, 2014
- Bristol-Myers Squibb Company
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,796,466
- Issue date Aug 5, 2014
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,722,688
- Issue date May 13, 2014
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,618,153
- Issue date Dec 31, 2013
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,552,047
- Issue date Oct 8, 2013
- Bristol-Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,536,338
- Issue date Sep 17, 2013
- Bristol-Myers Squibb Company
- Richard Pracitto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
- Patent number 8,431,568
- Issue date Apr 30, 2013
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,377,980
- Issue date Feb 19, 2013
- Bristol-Myers Squibb Company
- Makonen Belema
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,309,558
- Issue date Nov 13, 2012
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,293,909
- Issue date Oct 23, 2012
- Bristol-Myers Squibb Company
- Richard Pracitto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,198,449
- Issue date Jun 12, 2012
- Bristol-Myers Squibb Company
- Richard Pracitto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,148,382
- Issue date Apr 3, 2012
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,143,414
- Issue date Mar 27, 2012
- Bristol-Myers Squibb Company
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 8,143,244
- Issue date Mar 27, 2012
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhib...
- Patent number 8,138,171
- Issue date Mar 20, 2012
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 8,129,367
- Issue date Mar 6, 2012
- Bristol-Myers Squibb Company
- Piyasena Hewawasam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 8,124,601
- Issue date Feb 28, 2012
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors
- Patent number 8,119,628
- Issue date Feb 21, 2012
- Bristol-Myers Squibb Company
- Zhong Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,048,887
- Issue date Nov 1, 2011
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,994,171
- Issue date Aug 9, 2011
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
4-OXO-3,4-DIHYDROQUINAZOLINE COMPOUNDS AS INHIBITORS OF HUMAN IMMUN...
- Publication number 20210024503
- Publication date Jan 28, 2021
- VIIV HEALTHCARE UK (NO.5) LIMITED
- Makonen BELEMA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20180086697
- Publication date Mar 29, 2018
- John A. BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20180072997
- Publication date Mar 15, 2018
- ViiV HEATHCARE UK (NO.5) LIMITED
- John A. BENDER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HEPATITIS C VIRUS INHIBITOR
- Publication number 20170355689
- Publication date Dec 14, 2017
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20170304239
- Publication date Oct 26, 2017
- VIIV HEALTHCARE UK (NO.5) LIMITED
- Makonen BELEMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20160338999
- Publication date Nov 24, 2016
- Bristol-Myers Squibb Company
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV...
- Publication number 20160311806
- Publication date Oct 27, 2016
- Bristol-Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20160257645
- Publication date Sep 8, 2016
- Bristol-Myers Squibb Company
- Annapurna Pendri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS
- Publication number 20160052924
- Publication date Feb 25, 2016
- Bristol-Myers Squibb Company
- Tao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20150322048
- Publication date Nov 12, 2015
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20150252028
- Publication date Sep 10, 2015
- BRISTOL-MYERS SQUIBB COMPANY
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20150197499
- Publication date Jul 16, 2015
- Bristol-Myers Squibb Company
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20140205564
- Publication date Jul 24, 2014
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20140186299
- Publication date Jul 3, 2014
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20140045816
- Publication date Feb 13, 2014
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20140018389
- Publication date Jan 16, 2014
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20140012020
- Publication date Jan 9, 2014
- Omar D. Lopez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20130197012
- Publication date Aug 1, 2013
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20130171098
- Publication date Jul 4, 2013
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130121957
- Publication date May 16, 2013
- Bristol -Myers Squibb Company
- Qi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130115193
- Publication date May 9, 2013
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130028859
- Publication date Jan 31, 2013
- Bristol -Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130012540
- Publication date Jan 10, 2013
- Bristol -Myers Squibb Company
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20120316126
- Publication date Dec 13, 2012
- Bristol -Myers Squibb Company
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20120232099
- Publication date Sep 13, 2012
- Bristol -Myers Squibb Company
- Richard Pracitto
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
- Publication number 20120201783
- Publication date Aug 9, 2012
- Bristol -Myers Squibb Company
- Kap-Sun Yeung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20120195857
- Publication date Aug 2, 2012
- Bristol -Myers Squibb Company
- Makonen Belema
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20120115847
- Publication date May 10, 2012
- Bristol -Myers Squibb Company
- Piyasena Hewawasam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20110311480
- Publication date Dec 22, 2011
- Bristol -Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20110286961
- Publication date Nov 24, 2011
- Bristol -Myers Squibb Company
- Makonen Belema
- C07 - ORGANIC CHEMISTRY

John A. Bender

Person

Patents Grantslast 30 patents

4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immun...

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Hepatitis C virus inhibitors

2-keto amide derivatives as HIV attachment inhibitors

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Compounds for the treatment of hepatitis C

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Compounds for the treatment of hepatitis C

Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors

Hepatitis C virus inhibitors

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Hepatitis C virus inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhib...

Compounds for the treatment of Hepatitis C

Compounds for the treatment of Hepatitis C

Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Patents Applicationslast 30 patents

4-OXO-3,4-DIHYDROQUINAZOLINE COMPOUNDS AS INHIBITORS OF HUMAN IMMUN...

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

HEPATITIS C VIRUS INHIBITOR

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

HEPATITIS C VIRUS INHIBITORS

4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV...

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

Hepatitis C Virus Inhibitors

HEPATITIS C VIRUS INHIBITORS

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Compounds for the Treatment of Hepatitis C

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

Hepatitis C Virus Inhibitors

Compounds for the Treatment of Hepatitis C

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Hepatitis C Virus Inhibitors